Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH):recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35–40 years: a German database study
-
Published:2023-11
Issue:
Volume:
Page:103725
-
ISSN:1472-6483
-
Container-title:Reproductive BioMedicine Online
-
language:en
-
Short-container-title:Reproductive BioMedicine Online
Author:
Bielfeld A.P.,Schwarze J.E.,Verpillat P.,Lispi M.,Fischer R.,Hayward B.,Chuderland D.,D'Hooghe T.,Krussel J.S.
Funder
Merck Healthcare KGaA
Subject
Developmental Biology,Reproductive Medicine,Obstetrics and Gynecology